OE
Ostertag Eric Chief Executive Officer
CEO M
US US · SEC (Form 4)
Discover the detailed record of transactions filed by Ostertag Eric, Chief Executive Officer. Insider active across 1 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 26 reports have been logged. Total volume traded: €1.6m. The latest transaction was filed on 30 December 2021 — Don. Regulator: SEC (Form 4). All data is openly available.
Declarations 26 total
093,955 shares 0
Common Stock
SEC:0001209191-22-006170 · 30 Dec 2021
093,955 shares 0
Common Stock
SEC:0001209191-22-006170:0 · 30 Dec 2021
€8,049 1,000 shares @ €8.0486 0.5% of flow
Common Stock
SEC:0001209191-21-066229 · 19 Nov 2021
€8,049 1,000 shares @ €8.0486 0.2% of flow
Common Stock
SEC:0001209191-21-066229:0 · 19 Nov 2021
€60,507 9,873 shares @ €6.1285 3.4% of flow
Common Stock
SEC:0001209191-21-063934 · 8 Nov 2021
€60,507 9,873 shares @ €6.1285 1.7% of flow
Common Stock
SEC:0001209191-21-063934:0 · 8 Nov 2021
€146,709 18,525 shares @ €7.9195 8.4% of flow
Common Stock
SEC:0001209191-21-060403 · 11 Oct 2021
€146,709 18,525 shares @ €7.9195 4.1% of flow
Common Stock
SEC:0001209191-21-060403:0 · 11 Oct 2021
€63,380 10,450 shares @ €6.0651 3.6% of flow
Common Stock
SEC:0001209191-21-059651 · 1 Oct 2021
€63,380 10,450 shares @ €6.0651 1.8% of flow
Common Stock
SEC:0001209191-21-059651:0 · 1 Oct 2021
€136,417 20,000 shares @ €6.8209 7.8% of flow
Common Stock
SEC:0001209191-21-057289 · 20 Sept 2021
€136,417 20,000 shares @ €6.8209 3.8% of flow
Common Stock
SEC:0001209191-21-057289:0 · 20 Sept 2021
€2,738 2,757 shares @ €0.9931 0.2% of flow
Common Stock
SEC:0001209191-21-056246 · 13 Sept 2021
€2,738 2,757 shares @ €0.9931 0.1% of flow
Common Stock
SEC:0001209191-21-056246:0 · 13 Sept 2021
€190,664 26,686 shares @ €7.1447 10.9% of flow
Common Stock
SEC:0001209191-21-054797 · 1 Sept 2021
€190,664 26,686 shares @ €7.1447 5.3% of flow
Common Stock
SEC:0001209191-21-054797:0 · 1 Sept 2021
€859,275 111,149 shares @ €7.7308 48.9% of flow
Common Stock
SEC:0001209191-21-050697 · 6 Aug 2021
€859,275 111,149 shares @ €7.7308 24.0% of flow
Common Stock
SEC:0001209191-21-050697:0 · 6 Aug 2021
€49,069 7,167 shares @ €6.8465 2.8% of flow
Common Stock
SEC:0001209191-21-049673 · 2 Aug 2021
€49,069 7,167 shares @ €6.8465 1.4% of flow
Common Stock
SEC:0001209191-21-049673:0 · 2 Aug 2021
€88,486 10,729 shares @ €8.2473 5.0% of flow
Common Stock
SEC:0001209191-21-045591 · 1 Jul 2021
€88,486 10,729 shares @ €8.2473 2.5% of flow
Common Stock
SEC:0001209191-21-045591:0 · 1 Jul 2021
€151,464 21,493 shares @ €7.0471 8.6% of flow
Common Stock
SEC:0001209191-21-037931 · 1 Jun 2021
€151,464 21,493 shares @ €7.0471 4.2% of flow
Common Stock
SEC:0001209191-21-037931:0 · 1 Jun 2021
9,561 shares
Common Stock
SEC:0001209191-21-030484 · 3 May 2021
25 of 26 declarations
Load more (1 remaining) About Ostertag Eric Eric Ostertag is the Chief Executive Officer of Poseida Therapeutics, Inc.